Journal
DRUG DISCOVERY TODAY
Volume 27, Issue 6, Pages 1560-1574Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.02.015This
Keywords
Small molecule therapeutics; Drug discovery; Medicinal chemistry; New modalities; Arti ficial intelligence; Societal impact
Categories
Ask authors/readers for more resources
This article discusses the 125th anniversary of the Bayer Chemical Research Laboratory in Germany and highlights the significant contributions it has made to the development of small-molecule drugs. It also explores current and future trends in drug discovery, with a specific focus on small molecules.
The year 2021 marks the 125th anniversary of the Bayer Chemical Research Laboratory in Wuppertal, Germany. A significant number of prominent small-molecule drugs, from Aspirin to Xarelto, have emerged from this research site. In this review, we shed light on historic cornerstones of small-molecule drug research, discussing current and future trends in drug discovery as well as providing a personal outlook on the future of drug research with a focus on small molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available